- Home
- MTEN vs SNTI Comparison
MTEN vs SNTI Comparison
Compare MTEN & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- SNTI
- Stock Information
- Founded
- MTEN 2015
- SNTI 2016
- Country
- MTEN China
- SNTI United States
- Employees
- MTEN N/A
- SNTI N/A
- Industry
- MTEN Building Products
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- MTEN Industrials
- SNTI Health Care
- Exchange
- MTEN Nasdaq
- SNTI Nasdaq
- Market Cap
- MTEN 97.9M
- SNTI 85.3M
- IPO Year
- MTEN 2024
- SNTI N/A
- Fundamental
- Price
- MTEN $12.27
- SNTI $3.09
- Analyst Decision
- MTEN
- SNTI Strong Buy
- Analyst Count
- MTEN 0
- SNTI 1
- Target Price
- MTEN N/A
- SNTI $12.00
- AVG Volume (30 Days)
- MTEN 84.1K
- SNTI 26.4K
- Earning Date
- MTEN 04-30-2025
- SNTI 05-06-2025
- Dividend Yield
- MTEN N/A
- SNTI N/A
- EPS Growth
- MTEN N/A
- SNTI N/A
- EPS
- MTEN N/A
- SNTI N/A
- Revenue
- MTEN $10,120,257.00
- SNTI N/A
- Revenue This Year
- MTEN N/A
- SNTI N/A
- Revenue Next Year
- MTEN N/A
- SNTI N/A
- P/E Ratio
- MTEN N/A
- SNTI N/A
- Revenue Growth
- MTEN 23.03
- SNTI N/A
- 52 Week Low
- MTEN $1.81
- SNTI $1.52
- 52 Week High
- MTEN $16.60
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- MTEN N/A
- SNTI 43.14
- Support Level
- MTEN N/A
- SNTI $3.03
- Resistance Level
- MTEN N/A
- SNTI $3.50
- Average True Range (ATR)
- MTEN 0.00
- SNTI 0.22
- MACD
- MTEN 0.00
- SNTI 0.00
- Stochastic Oscillator
- MTEN 0.00
- SNTI 12.77
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.